This guideline sets out an antimicrobial prescribing strategy for adults with leg ulcer infection. It aims to optimise antibiotic use and reduce antibiotic resistance.

This guideline covers the assessment and early management of fever (elevation of body temperature above the normal daily variation) with no obvious cause in children aged under 5 years. It aims to improve clinical assessment and diagnosis of serious illness among young children who present with fever in primary and secondary care.

This guideline covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.

This guideline sets out an antimicrobial prescribing strategy for adults, young people, children and babies aged 72 hours and over with cellulitis and erysipelas. It aims to optimise antibiotic use and reduce antibiotic resistance.

This guideline sets out an antimicrobial prescribing strategy for adults, young people, children and babies aged 72 hours and over with a confirmed diagnosis of community-acquired pneumonia. It aims to optimise antibiotic use and reduce antibiotic resistance.

This guideline covers the diagnosis and management of hypertension in adults, including people with type 2 diabetes. It aims to reduce the risk of cardiovascular problems such as heart attacks and strokes by helping healthcare professionals to diagnose hypertension accurately and treat it effectively.

This guideline covers the management of ulcerative colitis (UC) in children, young people and adults. It aims to help professionals to provide consistent high-quality care and it highlights the importance of advice and support for people with UC.

This guideline covers the management of Crohn’s disease in children, young people and adults. It aims to reduce people’s symptoms and maintain or improve their quality of life.

This guideline covers the assessment and management of urinary incontinence and pelvic organ prolapse in women.

This guideline sets out an antimicrobial prescribing strategy for managing and preventing acute exacerbations of bronchiectasis (non-cystic fibrosis). It aims to optimise antibiotic use and reduce antibiotic resistance.

This guideline covers diagnosis and management of COPD in people aged =16 years, which includes emphysema and chronic bronchitis. It covers stable COPD and exacerbations. It replaces NICE CG101 (June 2010) summarised in NICE Bites No.19.

This edition includes four antimicrobial prescribing guidelines: 1.Pyelonephritis, 2. Lower urinary tract infection (UTI), 3. Recurrent UTI, 4. Catheter-associated UTI.

This guideline sets out an antimicrobial prescribing strategy for acute prostatitis. It aims to optimise antibiotic use and reduce antibiotic resistance.

This guideline covers the diagnosis and management of chronic HF in people aged =18 years.

This guideline covers the diagnosis and management of dementia including Alzheimer’s disease.

This guideline covers the management of Lyme disease in children (<12 years), young people (=12 years) and adults, including pregnant women.

This guideline update covers diagnosing and managing peripheral arterial disease (PAD) in people aged 18 years and older.

This guideline covers diagnosing, monitoring and managing asthma in adults and young people/children. It does not cover managing severe asthma or acute asthma attacks.

This guideline covers diagnosis and management of chronic open-angle glaucoma (COAG) and ocular hypertension (OHT) in adults aged 18 years and older.

This guideline sets out an antimicrobial prescribing strategy for acute sinusitis. It aims to limit antibiotic use and reduce antimicrobial resistance.

This guideline offers best practice advice on the assessment of fragility fracture risk in adults.

This guideline covers the diagnosis and management of Parkinson’s disease in people aged 18 years and older.

This guideline covers recognition and treatment of eating disorders including anorexia nervosa, binge eating and bulimia nervosa for children, young people and adults.

This guideline covers the assessment and management of cerebral palsy in under 25s.

This guideline has been developed to help ensure that adults aged 18 years and olderwho receive social care in the community get the support needed to manage their medicines safely and effectively.

This guideline covers the diagnosis and management of suspected or confirmed spondyloarthritis in adults 16 years and older.

This guideline aims to change people’s behaviour to reduce antimicrobial resistance and the spread of resistant microbes. It

This guideline covers the assessment and management of low back pain with or without sciatica in people aged 16 years and older.

In 2016 we carried out a user survey to find out,Who uses NICE Bites, how they access it and what it is used for,What is the value/impact for users?,Is the content and format useful?,How can NICE Bites be improved?

This guideline covers preventing, assessing and managing mental health problems in people with learning disabilities in all settings and should be used in conjunction with NICE guidelines on specific mental health problems.

This guideline covers optimising care for adults with multimorbidity, by reducing treatment burden (polypharmacy and multiple appointments) and unplanned care.

This guideline covers recognition, diagnosis and early management of sepsis for all populations. It should be used together with: algorithms organised by age group and treatment location and risk stratification tools.

This guideline covers identifying, assessing and managing NAFLD in children (1 to 15 years), young people (16 to 17 years) and adults (18 years and older).

This guideline covers systems and processes for using and managing CDs safely in all NHS settings except care homes.

This guideline includes recommendations on assessing and managing MND, a neurodegenerative condition affecting the brain and spinal cord. The most common type of MND is amyotrophic lateral sclerosis.

This guideline includes recommendations intended to help healthcare professionals recognise when a person may be entering the last days of their life, or if they may be deteriorating, stabilising or improving even temporarily.

This guideline offers advice on the care of people with, or at risk of contracting TB. It updates and replaces NICE CG117/PH37.

This guideline discusses the management of type 2 diabetes in adults.

This guideline covers diagnosis and management of menopause, including premature ovarian insufficiency.

This guideline discusses the management of type 1 and 2 diabetes in children and young people. Recommendations throughout this bulletin may refer to type 1 or 2 diabetes or both. This is clearly stated in each section.

This guideline discusses the management of type 1 diabetes in adults.

This guideline provides good practice recommendations on systems and processes for effective use of antimicrobials.

This guideline covers the management of anaemia associated with CKD in adults, children and young people.

This guideline covers the management of diabetes and its complications in women who are planning pregnancy and those already pregnant.

This guideline covers the identification and treatment of depression in children (aged 5 to 11 years) and young people (12 to 18 years) in primary, community and secondary care.

This guideline covers the diagnosis and management of adults with IBS in primary care.

This guideline offers best practice advice on the care of all people who are using medicines and also those who are receiving suboptimal benefit from medicinesa

This guideline covers the recognition, diagnosis and management of gastro-oesophageal reflux disease in infants, children and young people.

This guideline covers diagnosis and management of MS- related symptoms and treatment of relapse. Also see Box 1: NICE technology appraisals for disease-modifying treatments.

This guideline covers the diagnosis and management of community- and hospital-acquired pneumonia in adults.

This guideline covers the recognition, assessment and management of bipolar disorder in children, young people and adults. It applies to people with bipolar I, bipolar II, mixed affective and rapid cycling disorders.

This guideline gives recommendations on long-acting reversible contraception.

This guideline covers the management of dyspepsia and GORD in adults (>18 years). It also covers endoscopic surveillance for adults with a diagnosis of Barrett’s oesophagus, but does not include details on management of Barrett’s oesophagus.

This guideline covers the identification and management of CKD in adults in primary and secondary care.

This guideline covers the management of AF in adults (18 years and older) and includes people with paroxysmal (recurrent), persistent and permanent AF and atrial flutter, but does not apply to people with congenital heart disease precipitating AF.

This guideline includes recommendations on risk assessment for CVD and on the use of lipid-lowering drugs in adults.

This guideline covers people of all ages at risk of, or who have, a pressure ulcer.

This social care guideline provides recommendations for good practice on the systems and processes for managing medicines in care homes.

This guideline covers the treatment and management of psychosis and schizophrenia and related disorders in adults (18 years and older) with onset before 60 years. There is a separate NICE pathway on psychosis and schizophrenia in children and young people.

Recommendations in this guideline apply to men referred to secondary care with suspected or diagnosed prostate cancer, including follow-up in primary care once diagnosed.

This guideline covers secondary prevention after a myocardial infarction for patients in primary and secondary care. The guideline updates and replaces NICE CG48.